News from nls pharma group
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
31 May, 2017, 12:00 BST NLS Pharma Unveils Positive Phase 2 Data For NLS-1 (mazindol CR) In Adults With ADHD, Demonstrating Significant Improvement In Symptoms
- NLS-1 (mazindol CR) is not a stimulant, yet yields large effect size of 1.09 (using the ADHD-RS-DSM-5 scale) - 55% of patients in NLS-1 (mazindol...